Prasugrel API

Name	Prasugrel
Chinese name	普拉格雷
Cas Number	150322-73-9
Source	India
Qualifications	USDMF/-/-/-/-

Prasugrel is an oral antiplatelet drug jointly developed by Eli Lilly and its partner Daiichi Pharmaceutical Sankyo, and has been marketed in many countries. Prasugrel is a new type of antiplatelet drug, similar to clopidogrel, prasugrel selectively and irreversibly inhibits ADP-induced platelet aggregation, thereby exerting an antiplatelet effect. Pharmacological studies have shown that prasugrel has a faster onset than clopidogrel and has a stronger antiplatelet effect than clopidogrel. Clinical studies have shown that for patients with acute coronary syndrome before coronary intervention, prasugrel can reduce the incidence of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke, and has a quick effect, good curative effect, and good results. The drug resistance, bioavailability, and toxicity are also low.

Hot Tags: prasugrel api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Gabapentin API, Ranolazine API, Pabxilib API, Dimethyl Fumarate API, Letrozole API, Pleasant API

• Previous: Diacerein API
• Next: Lanthanum Carbonate API